Nephrocare Health Services intimates BSE and NSE of its upcoming board meeting on May 19, 2026.
Board will consider and approve audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Trading window for designated persons remains closed from April 1 to May 21, 2026, as per earlier intimation.